Related Experiment Videos
MR imaging of multiple sclerosis simulating brain tumor
N Kurihara1, S Takahashi, A Furuta
1Department of Radiology, Tohoku University School of Medicine, Sendai, Japan.
Clinical Imaging
|July 1, 1996
Summary
Multiple sclerosis can mimic brain tumors on CT and MR scans. Early detection strategies are crucial for differentiating these conditions, especially when biopsy is inconclusive, and steroid therapy can aid in lesion regression.
Area of Science:
- Neurology
- Radiology
- Oncology
Background:
- Multiple sclerosis (MS) can present as a solitary mass lesion.
- These lesions can be clinically and radiologically indistinguishable from primary brain tumors.
- Accurate differentiation is critical for appropriate patient management.
Observation:
- Two cases are presented where multiple sclerosis mimicked brain tumors on computed tomography (CT) and magnetic resonance (MR) imaging.
- One case was histopathologically confirmed as a demyelinating disease via biopsy.
- The second case was suggestive of demyelinating disease based on clinical and imaging findings.
Findings:
- Steroid therapy led to the regression of lesions observed on both CT and MR scans in the presented cases.
- The study highlights the importance of considering demyelinating disease in the differential diagnosis of brain mass lesions.
- Integration of clinical presentation, imaging characteristics, and treatment response aids in diagnosis.
Implications:
- The findings suggest specific strategies for the early detection of multiple sclerosis presenting as a mass lesion.
- Developing diagnostic algorithms can improve the differentiation between MS and brain tumors.
- This can lead to earlier and more appropriate treatment, potentially improving patient outcomes.